deuterium oxide has been researched along with Cancer of Pancreas in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eto, H; Hyodo, F; Nakano, K; Utsumi, H | 1 |
| Alken, RG; Bader, Y; Fritzer-Szekeres, M; Grusch, M; Hartmann, J; Heller, N; Horvath, Z; Krupitza, G; Madlener, S; Maier, S; Oehler, L; Saiko, P; Szekeres, T | 1 |
| Nio, Y; Omori, H; Takeda, H; Tamura, K | 1 |
| Nio, Y; Tamura, K | 1 |
2 review(s) available for deuterium oxide and Cancer of Pancreas
| Article | Year |
|---|---|
[Application for therapeutic use of deuterium oxide (D2O) against human pancreatic cancer].
Topics: Animals; Cell Division; Cell Movement; Deuterium Oxide; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Pancreatic Neoplasms; Phagocytosis; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1996 |
[Newly-developing therapies of pancreatic cancer--immunotherapy, gene therapy, differentiation therapy, endocrine therapy and others].
Topics: Animals; Benzodiazepinones; Deuterium Oxide; Devazepide; Genetic Therapy; Humans; Immunotherapy; Pancreatic Neoplasms; Proglumide; Quinolones; Receptors, Cholecystokinin | 1997 |
2 other study(ies) available for deuterium oxide and Cancer of Pancreas
| Article | Year |
|---|---|
Selective Imaging of Malignant Ascites in a Mouse Model of Peritoneal Metastasis Using in Vivo Dynamic Nuclear Polarization-Magnetic Resonance Imaging.
Topics: Animals; Ascites; Cell Line, Tumor; Contrast Media; Deuterium Oxide; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Genes, Reporter; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peritoneal Neoplasms; Radiography; Transplantation, Heterologous | 2016 |
Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; Deuterium Oxide; Dose-Response Relationship, Drug; Drug Synergism; Gemcitabine; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Neoplastic Stem Cells; Pancreatic Neoplasms; Tumor Stem Cell Assay | 2008 |